Trials / Unknown
UnknownNCT04505943
Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion
Comparison of Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion in Nulliparous Women : a Randomized Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effect of vaginal dinoprostone versus vaginal misoprostol and Isonicotinic Acid Hydrazide administered before the copper intrauterine device(IUD) insertion in reducing IUD inertion pain and the difficulty in inserting the IUD in nulliparous women.
Detailed description
Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isonicotinic Acid Hydrazide | 2 vaginal tablet of isonicotinic acid hydrazide inserted by the study nurse12 hours before IUD insertion. |
| DRUG | dinoprostine | 2 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the study nurse 3 hours before IUD insertion. |
| DRUG | misoprostol | 2 vaginal tablet of misoprostol (200 mcg) (Misotac®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-07-30
- Completion
- 2021-09-30
- First posted
- 2020-08-10
- Last updated
- 2020-08-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04505943. Inclusion in this directory is not an endorsement.